Evidence map›Paper›PMID 39355395›Full record

ArticleWorld journal of radiology2024

Myelin oligodendrocyte glycoprotein-associated transverse myelitis after SARS-CoV-2 infection: A case report.

Jian-Rong Zheng, Jun-Lei Chang, Jun Hu, Zhi-Jian Lin, Kai-Hua Lin, Bi-Hua Lu, Xu-Hui Chen, Zhi-Gang Liu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jian-Rong ZhengDepartment of Neurology, Peking University Shenzhen Hospital, Shenzhen 518000, Guangdong Province, China.
Jun-Lei ChangInstitute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518000, Guangdong Province, China.
Jun HuDepartment of Neurology, Peking University Shenzhen Hospital, Shenzhen 518000, Guangdong Province, China.
Zhi-Jian LinDepartment of Neurology, Peking University Shenzhen Hospital, Shenzhen 518000, Guangdong Province, China.
Kai-Hua LinDepartment of Neurology, Peking University Shenzhen Hospital, Shenzhen 518000, Guangdong Province, China.
Bi-Hua LuDepartment of Neurology, The Sixth People's Hospital of Foshan Nanhai District, Foshan 528000, Guangdong Province, China.
Xu-Hui ChenDepartment of Neurology, Peking University Shenzhen Hospital, Shenzhen 518000, Guangdong Province, China. xuhuichen@pkuszh.com.
Zhi-Gang LiuLaboratory of Functional Chemistry and Nutrition of Food, Northwest A&F University, Yangling 712100, Shaanxi Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCases of myelin oligodendrocyte glycoprotein (MOG) antibody-related disease have a history of coronavirus disease 2019 infection or its vaccination before disease onset. Severe acute respiratory syndrome virus 2 (SARS-CoV-2) infection has been considered to be a trigger of central nervous system autoimmune diseases. CASE SUMMARY: Here we report a 20-year male with MOG-associated transverse myelitis after a SARS-CoV-2 infection. The patient received a near-complete recovery after standard immunological treatments.

conclusionAttention should be paid to the evaluation of typical or atypical neurological symptoms that may be triggered by SARS-CoV-2 infection.

Indexed as

Case reportCOVID-19Myelin oligodendrocyte glycoprotein antibody-associated diseaseMyelin oligodendrocyte glycoprotein antibody-associated encephalomyelitisSARS-CoV-2

Identifiers

PMID39355395
PMCPMC11440270

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.